Liquid chromatography/mass spectrometry-based plasma metabolic profiling study of escitalopram in subjects with major depressive disorder-Reference-Cited by-同舟云学术

Liquid chromatography/mass spectrometry-based plasma metabolic profiling study of escitalopram in subjects with major depressive disorder

Published:2018-03-14 Issue:5 Volume:53 Page:385-399
ISSN:1076-5174
Container-title:Journal of Mass Spectrometry
language:en
Short-container-title:J Mass Spectrom

Author:

Bandu Raju¹,Lee Hyun Jeong²,Lee Hyeong Min¹,Ha Tae Hyon³,Lee Heon-Jeong⁴,Kim Se Joo⁵,Ha Kyooseob⁶,Kim Kwang Pyo¹^ORCID

Affiliation:

1. Department of Applied Chemistry, Institute of Natural Science, Kyung Hee Medical Science Research Institute, College of Applied Science; Kyung Hee University; Yong-in 17104 Republic of Korea

2. Mental Health Clinic; National Cancer Center; Goyang Kyeonggi 10408 Republic of Korea

3. Department of Psychiatry; Seoul National University Bundang Hospital; Seongnam Kyeonggi 13620 Republic of Korea

4. Department of Psychiatry; Korea University College of Medicine; Seoul 02841 Republic of Korea

5. Department of Psychiatry and Institute of Behavioral Science in Medicine; Yonsei University, College of Medicine; Seoul 03722 Republic of Korea

6. Department of Psychiatry and Behavioral Neuroscience; Seoul National University College of Medicine; Seoul 08826 Republic of Korea

Funder

Korea Research Institute of Standards and Science

Development of Platform Technology for Innovative Medical Measurements Program

Ministry of Health and Welfare, Republic of Korea

Korea Health Industry Development Institute

Korea Health Technology R&D Project

Publisher

Wiley

Subject

Spectroscopy

Reference41 articles.

1. Social and economic burden of mood disorders;Simon;Biol Psychiatry,2003

2. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiologic literature;Ferrari;Psychol Med,2013

3. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review;Vaswani;Prog Neuro-Psychopharmacol Biol Psychiatry,2003

4. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression;Laugeray;Behav Brain Res,2010

5. Spectrophotometric determination of citalopram hydrobromide in pharmaceuticals;Narayana;J Mex Chem Soc,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Plasma Metabolic Profiles of the Antidepressant Escitalopram and Clinical Response in Subjects with Depression;Mass Spectrometry;2023-07-06

2. Gut Microbiota and Depressive Symptoms at the End of CRT for Rectal Cancer: A Cross-Sectional Pilot Study;Depression Research and Treatment;2021-12-29

3. Metabolomics-based discrimination of patients with remitted depression from healthy controls using 1H-NMR spectroscopy;Scientific Reports;2021-08-02

4. Untargeted Plasma Metabolomic Profiling in Patients with Major Depressive Disorder Using Ultra-High Performance Liquid Chromatography Coupled with Mass Spectrometry;Metabolites;2021-07-20

5. Determination of atomoxetine or escitalopram in human plasma by HPLC: Applications in neuroscience research studies;Int. Journal of Clinical Pharmacology and Therapeutics;2020-08-01